AI is 'next tool in the toolkit' for bioconvergence
The reach of artificial intelligence now spans the entire drug pipeline, prompting Big Pharma to reconsider outsourcing innovation.
1 September 2026•3 mins read
The reach of artificial intelligence now spans the entire drug pipeline, prompting Big Pharma to reconsider outsourcing innovation.